Matching slides 303,780
Current window 203,131-203,160
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

203,131-203,160 of 303,780

filter-aware
02
Absci | Investor Presentation Deck | 30 slidesAbsci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations 1 hit
05
Uses a Venn-style diagram to illustrate the small overlap between screening and successful drug candidates.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a flywheel/cycle diagram to represent the iterative nature of their platform.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The central circular diagram represents a flywheel or iterative process.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
The slide uses a process flow diagram to explain the drug discovery pipeline from patient cohort to manufacturing.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
The slide uses a process flow diagram to illustrate the transformation of biological targets into optimized drug candidates.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
The slide uses a process-flow visual to contrast discovery vs. optimization.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
12
The slide features the company logo and a stylized 'a' graphic.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
13
The slide highlights a specific Nature Biomedical Engineering paper as validation of the company's core technology approach.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
14
The slide uses a process flow diagram to show the transition from parental mAb to optimized mAb via AI.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
15
The slide outlines a technical methodology for biological data generation.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
16
The slide includes a small schematic icon representing the scatter plot and a callout box emphasizing the necessity of high-quality data for AI training.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
17
The table outlines the experimental design for antibody optimization models, specifically highlighting the differences in sampling strategies and mutational loads.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
The slide explains the methodology behind the dataset used for AI lead optimization, specifically focusing on the combinatorial space of amino acid mutations.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
19
Includes scatter plots showing correlation and a bar chart comparing model performance metrics against experimental replicates.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The chart shows density vs -log10Kd, comparing design vs validation vs measured trastuzumab.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
The slide highlights the methodology of sampling sequence space and validating predictive models against measured binding affinity.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The chart compares High vs Low Fidelity models with and without pretraining across different training data sizes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
23
The slide shows scatter plots for quadruple and quintuple mutants and a summary bar chart for performance metrics.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
24
The slide uses a combination of diagrams and a summary box to explain the methodology of using AI to predict antibody naturalness.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
The slide uses box plots and bar charts to show statistical correlation between naturalness and clinical/developability outcomes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
The slide uses box plots and density plots to demonstrate that higher naturalness correlates with better expression and lower mutational burden.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
27
The charts show the progression of antibody variants over generations, highlighting the improvement in ACE score and naturalness metrics.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
28
The slide uses a process diagram to illustrate the 'in silico' lead optimization workflow.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
29
The slide uses a process flow diagram to show the integration of AI in drug development.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
30
The slide uses a lightbulb icon as a metaphor for innovation.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations 1 hit
02
Includes a specific disclosure regarding Dr. Harvey Levy's role as a Principal Investigator and Consultant.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
03
Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slidesAeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
04
Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slidesAeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
05
The slide uses a Gantt-style bar chart to represent clinical trial phases for each drug program.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit